نتائج البحث - Fleischmann, Roy M

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable حسب Fleischmann, Roy M, van der Heijde, Désirée, Gardiner, Philip V, Szumski, Annette, Marshall, Lisa, Bananis, Eustratios

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoi... حسب Kavanaugh, Arthur, Fleischmann, Roy M, Emery, Paul, Kupper, Hartmut, Redden, Laura, Guerette, Benoit, Santra, Sourav, Smolen, Josef S

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a... حسب Fleischmann, Roy M, Alvarez, Daniel F, Bock, Amy E, Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®)... حسب Fleischmann, Roy M., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis حسب Fleischmann, Roy M., Bock, Amy E., Zhang, Wuyan, Godfrey, Charles M., Vranic, Ivana, Cronenberger, Carol, Dokoupilová, Eva

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial حسب Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis حسب Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis حسب Fleischmann, Roy M., Alten, Rieke, Pileckyte, Margarita, Lobello, Kasia, Hua, Steven Y., Cronenberger, Carol, Alvarez, Daniel, Bock, Amy E., Sewell, K. Lea

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation حسب Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insuf... حسب Fleischmann, Roy M, Genovese, Mark C, Enejosa, Jeffrey V, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles, Durez, Patrick, Ostor, Andrew, Li, Yihan, Song, In-Ho

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients حسب van Vollenhoven, Ronald F, Emery, Paul, Bingham, Clifton O, Keystone, Edward C, Fleischmann, Roy M, Furst, Daniel E, Tyson, Nicola, Collinson, Neil, Lehane, Patricia B

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the r... حسب Huizinga, Tom W J, Fleischmann, Roy M, Jasson, Martine, Radin, Allen R, van Adelsberg, Janet, Fiore, Stefano, Huang, Xiaohong, Yancopoulos, George D, Stahl, Neil, Genovese, Mark C

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial حسب Stohl, William, Gomez-Reino, Juan, Olech, Ewa, Dudler, Jean, Fleischmann, Roy M, Zerbini, Cristiano A F, Ashrafzadeh, Ali, Grzeschik, Susanna, Bieraugel, Rebecca, Green, Jennifer, Francom, Steven, Dummer, Wolfgang

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis حسب Fleischmann, Roy M, Blanco, Ricardo, Hall, Stephen, Thomson, Glen T D, Van den Bosch, Filip E, Zerbini, Cristiano, Bessette, Louis, Enejosa, Jeffrey, Li, Yihan, Song, Yanna, DeMasi, Ryan, Song, In-Ho

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1) حسب Chandran, Vinod, van der Heijde, Désirée, Fleischmann, Roy M, Lespessailles, Eric, Helliwell, Philip S, Kameda, Hideto, Burgos-Vargas, Ruben, Erickson, Janelle S, Rathmann, Suchitrita S, Sprabery, Aubrey Trevelin, Birt, Julie A, Shuler, Catherine L, Gallo, Gaia

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial حسب Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo, Han, Chenglong, Gathany, Timothy A., Xu, Stephen, Zhou, Yiying, Leu, Jocelyn H., Hsia, Elizabeth C.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand os... حسب Kloppenburg, Margreet, Peterfy, Charles, Haugen, Ida K, Kroon, Féline, Chen, Su, Wang, Li, Liu, Wei, Levy, Gwen, Fleischmann, Roy M, Berenbaum, Francis, van der Heijde, Désirée, Bansal, Prashant, Wittoek, Ruth, Feng, Sheng, Fang, Yuni, Saltarelli, Mary, Medema, Jeroen K, Levesque, Marc C

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10 حسب Zanin-Zhorov, Alexandra, Weiss, Jonathan M., Trzeciak, Alissa, Chen, Wei, Zhang, Jingya, Nyuydzefe, Melanie S., Arencibia, Carmen, Polimera, Seetharam, Schueller, Olivier, Fuentes-Duculan, Judilyn, Bonifacio, Kathleen M., Kunjravia, Norma, Cueto, Inna, Soung, Jennifer, Fleischmann, Roy M., Kivitz, Alan, Lebwohl, Mark, Nunez, Margarita, Woodson, Johnnie, Smith, Shondra L., West, Robert F., Berger, Mark, Krueger, James G., Ryan, John L., Waksal, Samuel D.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement حسب Nash, Peter, Kerschbaumer, Andreas, Dörner, Thomas, Dougados, Maxime, Fleischmann, Roy M, Geissler, Klaus, McInnes, Iain, Pope, Janet E, van der Heijde, Désirée, Stoffer-Marx, Michaela, Takeuchi, Tsutomu, Trauner, Michael, Winthrop, Kevin L, de Wit, Maarten, Aletaha, Daniel, Baraliakos, Xenofon, Boehncke, Wolf-Henning, Emery, Paul, Isaacs, John D, Kremer, Joel, Lee, Eun Bong, Maksymowych, Walter P, Voshaar, Marieke, Tam, Lai-Shan, Tanaka, Yoshiya, van den Bosch, Filip, Westhovens, René, Xavier, Ricardo, Smolen, Josef S

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل